Genetic alterations in prostate cancer Jonathan L. ChinRobert E. Reiter OriginalPaper Pages: 157 - 165
Patterns of practice in the United States: Insights from CaPSURE on prostate cancer management Matthew R. CooperbergJeanette M. BroeringPeter R. Carroll OriginalPaper Pages: 166 - 172
Three-dimensional conformal brachytherapy for prostate cancer Michael J. Zelefsky OriginalPaper Pages: 173 - 178
Management of patients with an increasing prostate-specific antigen after radical prostatectomy Masood A. KhanAlan W. Partin OriginalPaper Pages: 179 - 187
Early versus late hormonal therapy for prostate cancer Hiroshi MiyamotoEdward M. Messing OriginalPaper Pages: 188 - 196
High-dose intensity modulated radiation therapy for prostate cancer Deborah A. KubanLei Dong OriginalPaper Pages: 197 - 202
Molecular diagnosis of prostate cancer Eduardo I. CantoShahrokh F. ShariatKevin M. Slawin OriginalPaper Pages: 203 - 211
Sexual health recovery after prostatectomy, external radiation, or brachytherapy for early stage prostate cancer Brent K. HollenbeckRodney L. DunnMartin G. Sanda OriginalPaper Pages: 212 - 219
Screening for prostate cancer: Updated experience from the Tyrol study Wolfgang HorningerAndreas BergerGeorg Bartsch OriginalPaper Pages: 220 - 225
Extended and saturation needle biopsy for the diagnosis of prostate cancer Kristin L. ChrouserMichael M. Lieber OriginalPaper Pages: 226 - 230
Prostate-specific antigen and related isoforms in the diagnosis and management of prostate cancer Alexander HaeseMarkus GraefenHans Lilja OriginalPaper Pages: 231 - 240
